Literature DB >> 12780467

Substance use disorder comorbidity among inpatient youths with psychiatric disorder.

Harith Swadi1, Candace Bobier.   

Abstract

OBJECTIVE: Substance abuse/dependence has been reported to show significant association with psychopathology, and is likely to influence the course and outcome of psychiatric illness. The aim of this study was to determine the rate of substance use disorders (other than alcohol) comorbidity among inpatient adolescents with severe Axis 1 psychiatric disorder.
METHOD: A retrospective analysis of systematically collected data was carried out. The subjects were 16-18-year-old youths, admitted to an inpatient unit for severe psychiatric disorder. The data collection process utilized the DSM-IV criteria for diagnostic categorization of psychiatric disorder and substance use disorder. Demographic data, and data on suicide attempts were also collected.
RESULTS: Over a period of one year (March 2001-March 2002), 62 patients were admitted to the Christchurch Youth Inpatient Unit; 40 (64.5%) had a comorbid Substance Abuse Disorder (SAD) according to DSM-IV criteria and none had a Substance Dependence Disorder. The vast majority involved cannabis and stimulants. Sixty per cent of those with mood disorder, 63% of those with anxiety disorder and 80% of those with schizophrenia spectrum disorder had a comorbid SAD. Internalizing problems, especially mood disorders, pre-dominated among those with SAD reflecting the Unit's admission criteria. There were no differences in attempted suicide rates between those with SAD and those without SAD, but those with SAD were more likely to have unstable accommodation/living arrangements than those without SAD.
CONCLUSIONS: Our findings confirm previous reports suggestive of high rates of SAD comorbidity among youth with severe psychiatric illness. There are clinical and process implications for these findings particularly identification of substance use disorders and their treatment as well as resource availability and staff training.

Entities:  

Mesh:

Year:  2003        PMID: 12780467     DOI: 10.1046/j.1440-1614.2003.01180.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  13 in total

1.  Effectiveness of a cognitive-behavioral therapy (CBT) manualized program for clinically anxious children: study protocol of a randomized controlled trial.

Authors:  Mélou Jansen; Marleen M E M van Doorn; Anna Lichtwarck-Aschoff; Rowella C W M Kuijpers; Huub Theunissen; Mirjam Korte; José van Rossum; Annemiek Wauben; Isabela Granic
Journal:  BMC Psychiatry       Date:  2012-03-12       Impact factor: 3.630

2.  Psychosocial and Clinical Correlates of Substance use Disorder in an Adolescent Inpatient Psychiatric Population.

Authors:  Marianne Daudin; David Cohen; Yves Edel; Nicolas Bonnet; Nicolas Bodeau; Angèle Consoli; Emmanuelle Deniau; Jean-Marc Guilé
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-11

Review 3.  Pharmacotherapy for schizophrenia and co-occurring substance use disorders.

Authors:  Alan I Green
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

4.  Patterns of substance use in adolescents attending a mental health department.

Authors:  Rosa Díaz; Javier Goti; Montse García; Antoni Gual; Lourdes Serrano; Laura González; Rosa Calvo; Josefina Castro-Fornieles
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04-21       Impact factor: 4.785

5.  The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use.

Authors:  Maju Mathew Koola; Heidi J Wehring; Deanna L Kelly
Journal:  J Dual Diagn       Date:  2012

Review 6.  Theoretical models of affectionate versus affectionless control in anxious families: a critical examination based on observations of parent-child interactions.

Authors:  Patricia Marten DiBartolo; Molly Helt
Journal:  Clin Child Fam Psychol Rev       Date:  2007-09

7.  Addiction epidemiology in adolescents receiving inpatient psychiatric treatment.

Authors:  Michael F Weaver; Madeleine A Dupre; Karen L Cropsey; J Randy Koch; Bela A Sood; Jenny L Wiley; Robert L Balster
Journal:  Addict Behav       Date:  2007-06-09       Impact factor: 3.913

8.  Schizophrenia: from epidemiology to rehabilitation.

Authors:  Gioia Mura; Donatella Rita Petretto; Krishna M Bhat; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-07-10

Review 9.  Interpreting the association between cannabis use and increased risk for schizophrenia.

Authors:  Mark Weiser; Shlomo Noy
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

Review 10.  Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.

Authors:  Marco Bortolato; Valentina Bini; Simone Tambaro
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.